Mitch Elkind

Department of Neurology, Columbia University, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Neurological Disorders > Cerebrovascular Disease (since 14 November 2005)

All recent recommendations

• 3.0
  Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
  Recommended by Mitch Elkind
  
• 3.0
  Statin treatment withdrawal in ischemic stroke: a controlled randomized study.
  Recommended by Mitch Elkind
  
• 3.0
  Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.
  Recommended by Mitch Elkind
  
• 3.0
  Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial.
  Recommended by Mitch Elkind
  
• 3.0
  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.
  Recommended by Mitch Elkind
  
• 6.0
  Evolution of hippocampal CA-1 diffusion lesions in transient global amnesia.
  Recommended by Mitch Elkind
  
• 3.0
  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.
  Recommended by Mitch Elkind
  
• 6.4
  COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.
  Recommended by Mitch Elkind, Albert Ong
  
• 4.8
  Incidence and prognosis of transient neurological attacks.
  Recommended by Mitch Elkind, Ralph Sacco with Sebastian Koch
  
• 6.4
  Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.
  Recommended by Mitch Elkind, Andreas Kramer with James Scozzafava
  
• 6.0
  Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack.
  Recommended by Mitch Elkind
  
• 3.0
  Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial.
  Recommended by Mitch Elkind
  
• 3.0
  Lipid levels and the risk of ischemic stroke in women.
  Recommended by Mitch Elkind
  
• 6.4
  Migraine and risk of cardiovascular disease in women.
  Recommended by Viola Vaccarino, Mitch Elkind
  
• 6.0
  High-dose atorvastatin after stroke or transient ischemic attack.
  Recommended by Mitch Elkind
  
• 3.0
  Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis.
  Recommended by Mitch Elkind
  
• 6.5
  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
  Recommended by Deepak Bhatt, Mitch Elkind, Hans-Christoph Diener
  
• 6.0
  NXY-059 for acute ischemic stroke.
  Recommended by Mitch Elkind
  
• 6.0
  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
  Recommended by Mitch Elkind
  
• 3.0
  Role of COL4A1 in small-vessel disease and hemorrhagic stroke.
  Recommended by Mitch Elkind
  
• 3.0
  Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups.
  Recommended by Mitch Elkind